-
JXE-23 Induces Protective Autophagy in HCC
2026-09-16
The 2024 reference study identifies JXE-23, a pimarane-type diterpene from Aleuritopteris albofusca, as a selective inhibitor of HepG2 hepatocellular carcinoma cell growth. Its combination of G2/M arrest, migration suppression, and protective autophagy connects the CIP2A/p-AKT/c-Myc axis with a potentially exploitable survival response in anticancer drug research.
-
Biotin-16-UTP: RNA Labeling Workflow Guide
2026-09-16
Biotin-16-UTP is a biotin-labeled uridine triphosphate for incorporating an affinity handle into RNA during in vitro transcription, supporting RNA detection and purification workflows. It is appropriate for controlled research assays, but labeled transcripts require empirical optimization and should not be treated as equivalent to native RNA without validation.
-
Amphotericin B: From Membrane Action to Assay Logic
2026-09-15
Amphotericin B is a polyene antifungal antibiotic whose sterol-dependent membrane activity can produce both fungal killing and mammalian-cell toxicity. This article develops an assay-interpretation framework, using a canine epithelial-cell study to show how viability, apoptosis, and inflammatory readouts should be integrated rather than interpreted in isolation.
-
Z-LEHD-FMK in Caspase-9 Apoptosis Assays
2026-09-15
Learn how Z-LEHD-FMK (SKU B3233) can clarify caspase-9-dependent apoptosis in viability, cytotoxicity, and cancer research workflows. This practical guide covers experimental design, stock preparation, data interpretation, and supplier-selection considerations.
-
L-Alanyl-L-Glutamine Workflow for GI Assays
2026-09-14
Build reproducible aqueous intestinal barrier, mucosal protection, and nutritional stress assays with a stable L-Ala-L-Gln dipeptide. This guide pairs practical preparation and dosing workflows with assay controls, troubleshooting, and a careful interpretation of antiviral screening evidence.
-
Topotecan (SKF104864): Applied Cancer Workflows
2026-09-14
Topotecan (SKF104864) provides a practical way to model topoisomerase I–linked DNA damage, cytostasis, and apoptosis across glioma and pediatric tumor systems. This workflow-focused guide connects dose design, kinetic readouts, combination testing, and troubleshooting to improve reproducibility in cancer research.
-
Z-YVAD-FMK: A Strategic Caspase-1 Inhibitor
2026-09-13
How Z-YVAD-FMK can help translational researchers distinguish caspase-1-driven pyroptosis from broader cell-death phenotypes, using the HOXC8–caspase-1 axis in lung cancer as a mechanistic framework.
-
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301)
2026-09-12
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnetic capture of biotinylated proteins, peptides, antibodies, sugars, oligonucleotides, and nucleic acids from complex samples. They are appropriate for affinity purification, immunoprecipitation, interaction studies, and screening workflows, but they are not a direct capture matrix for non-biotinylated targets and require validation for cell-compatible applications.
-
Deferasirox Fe3+ Chelate in Cell Assays
2026-09-11
A scenario-based guide to using Deferasirox Fe3+ chelate (SKU A3355) in cell viability, proliferation, and cytotoxicity workflows. It connects ferric iron biology with solvent control, assay compatibility, interpretation, and practical reagent selection.
-
WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis
2026-09-11
This study identifies the WNT5a/GSK3/β-catenin axis as a central regulator of adipogenic drift in skeletal-muscle fibro/adipogenic progenitors. By integrating pharmacological screening, mass cytometry, animal models, and transcriptomic network analysis, it links GSK3 inhibition and impaired WNT5a signaling to changes in muscle fat accumulation and regenerative support.
-
Matrine Assay Design: Reliable Cell Data
2026-09-10
This scenario-driven guide shows how Matrine, SKU A3583, can be evaluated in cell viability, proliferation, and cytotoxicity workflows without overextending model-specific evidence. It covers dose selection, solvent handling, orthogonal apoptosis readouts, cross-domain limitations, and practical vendor-selection criteria.
-
BFH772 (VEGFR2 inhibitor): Lab Workflow Guide
2026-09-10
BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of VEGFR2-mediated signaling and angiogenesis. This guide covers solvent selection, assay setup, storage, and QC while defining why it is unsuitable for water-based formulations, broad kinase inhibition, or direct clinical dosing decisions.
-
Amorolfine Hydrochloride Yeast Assays
2026-09-09
Build controlled yeast membrane-integrity assays that connect antifungal stress with ploidy, cell size, and survival. This workflow uses Amorolfine Hydrochloride as a tunable research reagent while separating membrane-specific effects from general growth inhibition and solvent artifacts.
-
Peroxynitrite, ER–Mitochondria Ca2+ Flux, and Necroptosis
2026-09-09
Liu et al. identify a mechanistic pathway linking hyperhomocysteinemia to cardiac microvascular ischemia–reperfusion injury: peroxynitrite induces ER stress, IP3R-dependent calcium transfer to mitochondria, mitochondrial oxidative stress, and necroptotic endothelial-cell death. The work provides a framework for interpreting calcium-handling interventions and designing follow-up necroptosis assays that distinguish upstream stress from MLKL-dependent membrane injury.
-
FITC-Concanavalin A (ConA) Workflow Guide
2026-09-08
FITC-Concanavalin A (ConA) Conjugate provides direct fluorescent detection of accessible α-D-glucose and α-D-mannose moieties on cells, tissues, and other glycoprotein-containing samples. It is suited to carbohydrate-focused immunofluorescence, flow cytometry, and glycobiology workflows, but not to non-carbohydrate targets or experiments outside the stated storage and stability conditions.